Clinicopathological implications of immunohistochemical expression of TBX21, CXCR3, GATA3, CCR4, and TCF1 in nodal follicular helper T-cell lymphoma and peripheral T-cell lymphoma, not otherwise specified

키워드

참고문헌 (45)

1. Swerdlow SH, "WHO classification of tumours of haematopoietic and lymphoid tissues" (2017), World Health Organization
2. Alaggio R, "The 5th edition of the World Health Organization classification of haematolymphoid tumours : lymphoid neoplasms", Leukemia, 36, pp.1720~1748 (2022)
3. Campo E, "The International Consensus Classification of Mature Lymphoid Neoplasms : a report from the Clinical Advisory Committee", Blood, 140, pp.1229~1253 (2022)
4. Vallois D, "Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell-derived lymphomas", Blood, 128, pp.1490~1502 (2016)
5. Palomero T, "Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas", Nat Genet, 46, pp.166~170 (2014)
6. Lemonnier F, "Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters", Blood, 120, pp.1466~1469 (2012)
7. Yoo HY, "A recurrent inactivating mutation in RHOA GTPase in angioimmunoblastic T cell lymphoma", Nat Genet, 46, pp.371~375 (2014)
8. Sakata-Yanagimoto M, "Somatic RHOA mutation in angioimmunoblastic T cell lymphoma", Nat Genet, 46, pp.171~175 (2014)
9. Dobay MP, "Integrative clinicopathological and molecular analyses of angioimmunoblastic T-cell lymphoma and other nodal lymphomas of follicular helper T-cell origin", Haematologica, 102, pp.e148~e151 (2017)
10. Sandell RF, "Genetic landscape and classification of peripheral T cell lymphomas", Curr Oncol Rep, 19, pp.28~ (2017)
11. Ondrejka SL, "Follicular helper T-cell lymphomas: disease spectrum, relationship with clonal hematopoiesis, and mimics. A report of the 2022 EA4HP", SH lymphoma workshop, 2023, pp.483, 349~365
12. Vega F, "A suggested immunohistochemical algorithm for the classification of T-cell lymphomas involving lymph nodes", Hum Pathol, 102, pp.104~116 (2020)
13. Basha BM, "Application of a 5 marker panel to the routine diagnosis of peripheral T-cell lymphoma with T-follicular helper phenotype", Am J Surg Pathol, 43, pp.1282~1290 (2019)
14. Kim C, "The transcription factor TCF1 in T cell differentiation and aging", Int J Mol Sci, 21, pp.6497~ (2020)
15. Qiu H, "Transcriptional and epigenetic regulation of follicular T-helper cells and their role in autoimmunity", Autoimmunity, 50, pp.71~81 (2017)
16. Wang T, "GATA-3 expression identifies a high-risk subset of PTCL, NOS with distinct molecular and clinical features", Blood, 123, pp.3007~3015 (2014)
17. Iqbal J, "Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma", Blood, 115, pp.1026~1036 (2010)
18. Heavican TB, "Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma", Blood, 133, pp.1664~1676 (2019)
19. Iqbal J, "Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma", Blood, 123, pp.2915~2923 (2014)
20. Amador C, "Reproducing the molecular subclassification of peripheral T-cell lymphoma-NOS by immunohistochemistry", Blood, 134, pp.2159~2170 (2019)
21. Ioannidou K, "In situ characterization of follicular helper CD4 T cells using multiplexed imaging", Front Immunol, 11, pp.607626~ (2020)
22. Wang P, "The transcription factor T-bet is required for optimal type I follicular helper T cell maintenance during acute viral infection", Front Immunol, 10, pp.606~ (2019)
23. Sheikh AA, "Transcription tipping points for T follicular helper cell and T-helper 1 cell fate commitment", Cell Mol Immunol, 18, pp.528~538 (2021)
24. Schmitt N, "Phenotype and functions of memory Tfh cells in human blood", Trends Immunol, 35, pp.436~442 (2014)
25. Paik JH, "Distinct and overlapping features of nodal peripheral T-cell lymphomas exhibiting a follicular helper Tcell phenotype : a multicenter study emphasizing the clinicopathological significance of follicular helper T-cell marker expression", Hum Pathol, 131, pp.47~60 (2023)
26. Kim S, "Clinicopathological features of programmed cell death-1 and programmed cell death-ligand-1 expression in the tumor cells and tumor microenvironment of angioimmunoblastic T cell lymphoma and peripheral T cell lymphoma not otherwise specified", Virchows Arch, 477, pp.131~142 (2020)
27. Vega F, "Genetic profiling and biomarkers in peripheral T-cell lymphomas : current role in the diagnostic work-up", Mod Pathol, 35, pp.306~318 (2022)
28. Ghione P, "T follicular helper phenotype predicts response to histone deacetylase inhibitors in relapsed", refractory peripheral T-cell lymphoma, 2020, pp.4, 4640~4647
29. Drieux F, "How molecular advances may improve the diagnosis and management of PTCL patients", Front Oncol, 13, pp.1202964~ (2023)
30. Yu S, "The TCF-1 and LEF-1 transcription factors have cooperative and opposing roles in T cell development and malignancy", Immunity, 37, pp.813~826 (2012)
31. Tiemessen MM, "The nuclear effector of Wnt-signaling, Tcf1, functions as a T-cell-specific tumor suppressor for development of lymphomas", PLoS Biol, 10, pp.e1001430~ (2012)
32. Arnovitz S, "Tcf-1 promotes genomic instability and T cell transformation in response to aberrant betacatenin activation", Proc Natl Acad Sci U S A, 119, pp.e2201493119~ (2022)
33. Dorfman DM, "Loss of expression of the WNT", beta-catenin-signaling pathway transcription factors lymphoid enhancer factor-1(LEF-1)and T cell factor-1(TCF-1)in a subset of peripheral T cell lymphomas, 2003, pp.162, 1539~1544
34. Yoon SE, "Comprehensive analysis of clinical, pathological, and genomic characteristics of follicular helper T-cell derived lymphomas", Exp Hematol Oncol, 10, pp.33~ (2021)
35. Geng X, "GATA-3 is a proto-oncogene in Tcell lymphoproliferative neoplasms", Blood Cancer J, 12, pp.149~ (2022)
36. Maura F, "CDKN2A deletion is a frequent event associated with poor outcome in patients with peripheral Tcell lymphoma not otherwise specified(PTCL-NOS)", Haematologica, 106, pp.2918~2926 (2021)
37. Ishida T, "The CC chemokine receptor 4 as a novel specific molecular target for immunotherapy in adult TCell leukemia", lymphoma, 2004, pp.10, 7529~7539
38. Ishida T, "CXC chemokine receptor 3 and CC chemokine receptor 4 expression in T-cell and NK-cell lymphomas with special reference to clinicopathological significance for peripheral T-cell lymphoma, unspecified", Clin Cancer Res, 10, pp.5494~5500 (2004)
39. Asano N, "Linkage of expression of chemokine receptors(CXCR3 and CCR4)and cytotoxic molecules in peripheral T cell lymphoma, not otherwise specified and ALK-negative anaplastic large cell lymphoma", Int J Hematol, 91, pp.426~435 (2010)
40. Campbell JJ, "Sezary syndrome and mycosis fungoides arise from distinct T-cell subsets : a biologic rationale for their distinct clinical behaviors", Blood, 116, pp.767~771 (2010)
41. Ishida T, "Clinical significance of CCR4expression in adult T-cell leukemia", lymphoma : its close association with skin involvement and unfavorable outcome, 2003, pp.9, 3625~3634
42. Ureshino H, "Mogamulizumab for the treatment of adult T-cell leukemia", lymphoma, 2019, pp.19, 326~331
43. Kasamon YL, "FDA Approval summary : mogamulizumab-kpkc for mycosis fungoides and Sezary syndrome", Clin Cancer Res, 25, pp.7275~7280 (2019)
44. Ogura M, "Multicenter phase II study of mogamulizumab(KW-0761), a defucosylated anti-cc chemokine receptor 4 antibody, in patients with relapsed peripheral T-cell lymphoma and cutaneous T-cell lymphoma", J Clin Oncol, 32, pp.1157~1163 (2014)
45. Ngu HS, "Past, present and future therapeutic approaches in nodal peripheral T-cell lymphomas", Haematologica, 108, pp.3211~3226 (2023)

관련 논문AI추천